Global Granulocyte-Colony Stimulating Factor Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152790
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 119
  • list Pharmaceuticals and Healthcare

Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cellsand release them into the bloodstream.

Scope of the Report:

Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. 

The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.

G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.

The worldwide market for Granulocyte-Colony Stimulating Factor is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Granulocyte-Colony Stimulating Factor in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

BioCad

Dong-A Socio Group

Pfizer

Intas Pharmaceuticals

Novartis AG

Stada Arzneimittel

Teva Pharmaceutical Industries

Amgen

Dr. Reddy's Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Capsules

Tablets

Others

Market Segment by Applications, can be divided into

Oncological Diseases

Blood Disorders

Growth Hormone Deficiencies

Chronic and Autoimmune Disorders

Others

There are 15 Chapters to deeply display the global Granulocyte-Colony Stimulating Factor market.

Chapter 1, to describe Granulocyte-Colony Stimulating Factor Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Granulocyte-Colony Stimulating Factor, with sales, revenue, and price of Granulocyte-Colony Stimulating Factor, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Granulocyte-Colony Stimulating Factor, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Granulocyte-Colony Stimulating Factor market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Granulocyte-Colony Stimulating Factor sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Granulocyte-Colony Stimulating Factor Introduction

1.2 Market Analysis by Type

1.2.1 Capsules

1.2.2 Tablets

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Oncological Diseases

1.3.2 Blood Disorders

1.3.3 Growth Hormone Deficiencies

1.3.4 Chronic and Autoimmune Disorders

1.3.5 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 BioCad

2.1.1 Business Overview

2.1.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 BioCad Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Dong-A Socio Group

2.2.1 Business Overview

2.2.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pfizer

2.3.1 Business Overview

2.3.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Intas Pharmaceuticals

2.4.1 Business Overview

2.4.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novartis AG

2.5.1 Business Overview

2.5.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novartis AG Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Stada Arzneimittel

2.6.1 Business Overview

2.6.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Teva Pharmaceutical Industries

2.7.1 Business Overview

2.7.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Amgen

2.8.1 Business Overview

2.8.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Amgen Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Dr. Reddy's Laboratories

2.9.1 Business Overview

2.9.2 Granulocyte-Colony Stimulating Factor Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Granulocyte-Colony Stimulating Factor Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Granulocyte-Colony Stimulating Factor Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Granulocyte-Colony Stimulating Factor Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Granulocyte-Colony Stimulating Factor Manufacturer Market Share in 2017

3.3.2 Top 6 Granulocyte-Colony Stimulating Factor Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Granulocyte-Colony Stimulating Factor Market Analysis by Regions

4.1 Global Granulocyte-Colony Stimulating Factor Sales, Revenue and Market Share by Regions

4.1.1 Global Granulocyte-Colony Stimulating Factor Sales and Market Share by Regions (2013-2018)

4.1.2 Global Granulocyte-Colony Stimulating Factor Revenue and Market Share by Regions (2013-2018)

4.2 North America Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

4.3 Europe Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

4.5 South America Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

5 North America Granulocyte-Colony Stimulating Factor by Countries

5.1 North America Granulocyte-Colony Stimulating Factor Sales, Revenue and Market Share by Countries

5.1.1 North America Granulocyte-Colony Stimulating Factor Sales and Market Share by Countries (2013-2018)

5.1.2 North America Granulocyte-Colony Stimulating Factor Revenue and Market Share by Countries (2013-2018)

5.2 United States Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

5.3 Canada Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

5.4 Mexico Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

6 Europe Granulocyte-Colony Stimulating Factor by Countries

6.1 Europe Granulocyte-Colony Stimulating Factor Sales, Revenue and Market Share by Countries

6.1.1 Europe Granulocyte-Colony Stimulating Factor Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Granulocyte-Colony Stimulating Factor Revenue and Market Share by Countries (2013-2018)

6.2 Germany Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

6.3 UK Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

6.4 France Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

6.5 Russia Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

6.6 Italy Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

7 Asia-Pacific Granulocyte-Colony Stimulating Factor by Countries

7.1 Asia-Pacific Granulocyte-Colony Stimulating Factor Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Granulocyte-Colony Stimulating Factor Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Granulocyte-Colony Stimulating Factor Revenue and Market Share by Countries (2013-2018)

7.2 China Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

7.3 Japan Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

7.4 Korea Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

7.5 India Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

8 South America Granulocyte-Colony Stimulating Factor by Countries

8.1 South America Granulocyte-Colony Stimulating Factor Sales, Revenue and Market Share by Countries

8.1.1 South America Granulocyte-Colony Stimulating Factor Sales and Market Share by Countries (2013-2018)

8.1.2 South America Granulocyte-Colony Stimulating Factor Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

8.3 Argentina Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

8.4 Colombia Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

9 Middle East and Africa Granulocyte-Colony Stimulating Factor by Countries

9.1 Middle East and Africa Granulocyte-Colony Stimulating Factor Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Granulocyte-Colony Stimulating Factor Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Granulocyte-Colony Stimulating Factor Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

9.3 UAE Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

9.4 Egypt Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

9.5 Nigeria Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

9.6 South Africa Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2013-2018)

10 Global Granulocyte-Colony Stimulating Factor Market Segment by Type

10.1 Global Granulocyte-Colony Stimulating Factor Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Granulocyte-Colony Stimulating Factor Sales and Market Share by Type (2013-2018)

10.1.2 Global Granulocyte-Colony Stimulating Factor Revenue and Market Share by Type (2013-2018)

10.2 Capsules Sales Growth and Price

10.2.1 Global Capsules Sales Growth (2013-2018)

10.2.2 Global Capsules Price (2013-2018)

10.3 Tablets Sales Growth and Price

10.3.1 Global Tablets Sales Growth (2013-2018)

10.3.2 Global Tablets Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Granulocyte-Colony Stimulating Factor Market Segment by Application

11.1 Global Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2013-2018)

11.2 Oncological Diseases Sales Growth (2013-2018)

11.3 Blood Disorders Sales Growth (2013-2018)

11.4 Growth Hormone Deficiencies Sales Growth (2013-2018)

11.5 Chronic and Autoimmune Disorders Sales Growth (2013-2018)

11.6 Others Sales Growth (2013-2018)

12 Granulocyte-Colony Stimulating Factor Market Forecast (2018-2023)

12.1 Global Granulocyte-Colony Stimulating Factor Sales, Revenue and Growth Rate (2018-2023)

12.2 Granulocyte-Colony Stimulating Factor Market Forecast by Regions (2018-2023)

12.2.1 North America Granulocyte-Colony Stimulating Factor Market Forecast (2018-2023)

12.2.2 Europe Granulocyte-Colony Stimulating Factor Market Forecast (2018-2023)

12.2.3 Asia-Pacific Granulocyte-Colony Stimulating Factor Market Forecast (2018-2023)

12.2.4 South America Granulocyte-Colony Stimulating Factor Market Forecast (2018-2023)

12.2.5 Middle East and Africa Granulocyte-Colony Stimulating Factor Market Forecast (2018-2023)

12.3 Granulocyte-Colony Stimulating Factor Market Forecast by Type (2018-2023)

12.3.1 Global Granulocyte-Colony Stimulating Factor Sales Forecast by Type (2018-2023)

12.3.2 Global Granulocyte-Colony Stimulating Factor Market Share Forecast by Type (2018-2023)

12.4 Granulocyte-Colony Stimulating Factor Market Forecast by Application (2018-2023)

12.4.1 Global Granulocyte-Colony Stimulating Factor Sales Forecast by Application (2018-2023)

12.4.2 Global Granulocyte-Colony Stimulating Factor Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Granulocyte-Colony Stimulating Factor Picture

Table Product Specifications of Granulocyte-Colony Stimulating Factor

Figure Global Sales Market Share of Granulocyte-C

Please fill the form below, to recieve the report sample


+1